Mitchell Scheiman, O.D.Mitchell Scheiman, O.D.

Professor
mscheiman@pco.edu 

Education:

B.S., O.D., New England College of Optometry

Role at PCO:

Clinical Research, Primary instructor NABF1 and 2, Director Pediatric/Binocular Vision Programs

Professional honors and activities:

  • AM Skeffington Award for excellence in writing. College of Optometrists in Vision Development 2003
  • ATS (Amblyopia Treatment Study) Steering Committee (2000-2004)
  • Classification of Eye Movements, Strabismus and Amblyopia Committee Member (CEMAS), National Institutes of Health
  • Consulting Author - Clinical Practice Guidelines Accommodative/Binocular Vision Disorders
  • Principal Author Clinical Practice Guidelines - Pediatric Examination, American Optometric Association

Clinical specialty: 

Vision Therapy, Binocular Vision, Pediatrics

Selected Representative Publications (From 108 Publications):

  1. Scheiman M, Mitchell GL, Cotter S, et al. Correspondence: Accommodative insufficiency is the primary source of symptoms in children diagnosed with convergence insufficiency. Optom Vis Sci 2006;83:857-858.
  2. Scheiman M, Scheiman M, Whittaker S.  Low Vision Rehabilitation: A Practical Guide for Occupational Therapists.  Slack Inc, Thorofare, NJ.  2007
  3. Scheiman, M. and Rouse M. Optometric Management of Learning Related Vision Problems, 2nd edition, 2005, CV Mosby Co.
  4. Scheiman M, Mitchell GL, Cotter S, et al. A randomized clinical trial of treatments for convergence insufficiency in children.  Arch Ophthalmol 2005;123:14-24.
  5. Scheiman M, Mitchell GL, Cotter S, et al. Letter to the Editor in reply to a randomized clinical trial of treatments for convergence insufficiency in children.  Arch Ophthalmol 2005;123:1760-1761.
  6. Scheiman M, Mitchell GL, Cotter S, et al. A randomized clinical trial of treatments for convergence insufficiency in young adults.  Opt Vis Sci 2005;82:583-595.
  7. Scheiman M, Mitchell GL, Cotter S, et al. A randomized clinical trial of base-in prism for convergence insufficiency in children 9-17 years..  Brit J Ophthalmol 2005;89:113-123.
  8. Rouse, MW, Borsting E, Mitchell GL, Scheiman M, Cotter S, Cooper J, Kulp MK, London R, Wensveen J, and the CITT Group.  Validity and reliability of the Convergence Insufficiency Symptom Survey in adults. Ophthal Physiol Opt. 2004;24:384-390
  9. Borsting E, Rouse, Mitchell GL, Scheiman M, Cotter S, Cooper J, Kulp MK, London R.  Validity and reliability of the Convergence Insufficiency Symptom Survey in children Opt Vis Sci 2003;80:832-838
  10. Scheiman M. Colored lenses to improve reading comfort and performance: Are underlying vision problems being missed?  J Optom Vis Dev 2004;35:37-41.
  11. The Pediatric Eye Disease Investigator Group (Scheiman M - Writing committee). A randomized trial of atropine regimens for treatment of moderate amblyopia in children.  Ophthalmol 2004;111:2076-2085.
  12. The Pediatric Eye Disease Investigator Group (Lead Authors: Scheiman M, Kraker, RT, Beck RW). A Prospective, Pilot Study of Treatment of Amblyopia in Children 10 to <18 years old. Am J Ophthalmol 2004;137:581-583.
  13. Scheiman M, Gallaway M, Frantz KA, Peters RJ, Hatch S, Cuff M, Mitchell GL.  Nearpoint of convergence: Test procedure, target selection, and normative data.  Opt Vis Sci 2003; 80:214-225
  14. The Pediatric Eye Disease Investigator Group. (Scheiman M – steering committee member). The course of moderate amblyopia treated with atropine in children: experience of the Amblyopia Treatment Study. American Journal of Ophthalmology 2003; 136:630-39
  15. The Pediatric Eye Disease Investigator Group. (Scheiman M - member of steering committee). The course of moderate amblyopia treated with patching in children: experience of the Amblyopia Treatment Study. American Journal of Ophthalmology 2003; 136:620-9
  16. The Pediatric Eye Disease Investigator Group (Scheiman M- member of writing and steering committees). A randomized trial of patching regimens for treatment of moderate amblyopia in children. Archives of Ophthalmology 2003; 121:603-611
  17. The Pediatric Eye Disease Investigator Group (Scheiman, M - member of writing and steering committees). A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003; 110(11): 2075-87
  18. Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci 2003;44:1492-1500.
  19. Scheiman M, Wick B. Clinical Management of Binocular Vision: Heterophoric, Accommodative and Eye Movement Disorders. 2nd edition, Lippincott, Philadelphia 2002
  20. Scheiman M. Understanding and Managing Visual Deficits: A Guide for Occupational Therapists. 2nd Edition, Slack Inc, Thorofare, NJ. 2002
  21.  Scheiman M, Cooper J, Mitchell L et al.  A survey of treatment modalities for convergence insufficiency. Opt Vis Sci. 2002. 79:151-157
  22.  Gallaway M, Scheiman M, Malhotra K. Effectiveness of pencil push-up treatment for convergence insufficiency Opt Vis Sci. 2002. 79: 265-267.
  23.  Scheiman, M, Gallaway M.  Vision therapy for the treatment of patients after acquired brain injury, in Visual and Vestibular Consequences of Acquired Brain Injury. Eds.  Suchoff I, Ciuffreda KJ, Kapoor N.  Optometric Extension Program, 2001, Santa Ana, CA.

Professional Activities/Recognition/Awards:

  • Plenary Session Speaker: American Academy of Optometry Annual meeting San Diego, CA 2005
  • Skeffington Award for Excellence in Writing. COVD Annual Conference, October 2002.
  • Garland Clay Award for excellence in writing; American Academy of Optometry Meeting December 1993
  • First Place, Best Non-Technical Article in the Optometric Literature, 1989, Optometric Editors Association

Research Activities:

  • Study Chair: Convergence Insufficiency Treatment Trial (CITT) NEI sponsored, October 2004 – September 2008
  • Principal Investigator: Base In – CITT Study, Lions sponsored, October 2003-September 2004
  • Principal Investigator: Correction of Myopia Evaluation Trial (COMET II), NEI sponsored 4-year grant,  March 2003-March 2007
  • Study Chair and PI: Convergence Insufficiency Treatment Trial Pilot Study (CITT), NEI sponsored, November 2000-October 2002
  • Co-Principal Investigator : Amblyopia Treatment Studies, NEI sponsored, March 2001 – Present
  • Principal Investigator, Correction of Myopia Evaluation Trial (COMET), NEI sponsored 5-year grant,  March 1997-March 2002     Completed

Updated 08/2007